Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Chovatiya, Raj [1 ]
Wollenberg, Andreas [2 ,3 ]
Ribero, Simone [4 ]
Saeki, Hidehisa [5 ]
Oland, Christian B. [6 ]
Steffensen, Louise A. [6 ]
Tindberg, Ann-Marie [6 ]
Thyssen, Jacob P. [6 ,7 ]
Blauvelt, Andrew [8 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Univ Hosp Augsburg, Augsburg, Germany
[3] Ludwig Maximilian Univ Munich, Munich, Germany
[4] Univ Turin, Turin, Italy
[5] Nippon Med Sch, Tokyo, Japan
[6] LEO Pharma AS, Ballerup, Denmark
[7] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[8] Oregon Med Res Ctr, Portland, OR USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷
关键词：
tralokinumab; moderate-to-severe; head; neck; efficacy;
D O I：
10.1093/bjd/ljad498.051
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
552
引用
收藏
页码：II49 / II50
页数：2
相关论文
共 50 条
  • [41] DUPILUMAB PROVIDES EARLY AND SUSTAINED IMPROVEMENT IN SLEEP IN ADOLESCENTS AND ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Beck, Lisa A.
    Simpson, Eric L.
    de Bruin-Weller, Marjolein
    Wollenberg, Andreas
    Kataoka, Yoko
    Barbarot, Sebastien
    Bansal, Ashish
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Prescilla, Randy
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 54 - 54
  • [42] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    Marjolein S. de Bruin-Weller
    Esther Serra-Baldrich
    Sebastien Barbarot
    Susanne Grond
    Christopher Schuster
    Helmut Petto
    Jean-Philippe Capron
    Afaf Raibouaa
    Thomas Werfel
    Dermatology and Therapy, 2022, 12 : 1481 - 1491
  • [43] Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest
    Reich, Kristian
    Simpson, Eric
    Langley, Richard
    Warren, Richard B.
    Costanzo, Antonio
    Saeki, Hidehisa
    Almgren, Peter
    Gjerum, Le
    Carlsson, Anna
    Gooderham, Melinda
    Pinter, Andreas
    Weller, Marjolein De Bruin
    Blauvelt, Andrew
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [44] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    de Bruin-Weller, Marjolein S.
    Serra-Baldrich, Esther
    Barbarot, Sebastien
    Grond, Susanne
    Schuster, Christopher
    Petto, Helmut
    Capron, Jean-Philippe
    Raibouaa, Afaf
    Werfel, Thomas
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1481 - 1491
  • [45] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [46] Lebrikizumab is an effective treatment for moderate-to-severe atopic dermatitis in patients ≥60 years of age
    Armstrong, April
    Zirwas, Matthew
    Napolitano, Maddalena
    Torres, Tiago
    Staumont-Salle, Delphine
    Atwater, Amber Reck
    Dossenbach, Martin
    Agell, Helena
    Chen, Sherry
    Qiao, Meihua
    Pierce, Evangeline
    Piruzeli, Maria Lucia Buziqui
    Mostaghimi, Arash
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [47] Clinical efficacy of fecal microbial transplantation treatment in adults with moderate-to-severe atopic dermatitis
    Mashiah, Jacob
    Karady, Tal
    Fliss-Isakov, Naomi
    Sprecher, Eli
    Slodownik, Dan
    Artzi, Ofir
    Samuelov, Liat
    Ellenbogen, Eran
    Godneva, Anastasia
    Segal, Eran
    Maharshak, Nitsan
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (03)
  • [48] Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Torres, Tiago
    Petersen, Anne Sohrt
    Ivens, Ulla
    Vilaro, Albert Bosch
    Stinson, John
    Carrascosa, Jose Manuel
    DERMATOLOGY AND THERAPY, 2024, 14 (04) : 983 - 992
  • [49] Tralokinumab treatment substantially improves patient-reported outcomes in adolescents with moderate-to-severe atopic dermatitis at 16 weeks
    Soong, Weily
    Blauvelt, Andrew
    Wollenberg, Andreas
    Hong, H. Chih-ho
    Leflein, Jeffrey
    Bewley, Anthony
    Amoudruz, Petra
    Moerch, Marie Holst
    Soldbro, Lise
    Schneider, Shannon
    Simpson, Eric L.
    Paller, Amy
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E91 - E92
  • [50] Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis
    Moore, C
    Ehlayel, MS
    Junprasert, J
    Sorensen, RU
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (05) : 452 - 458
12345